# Isotretinoin in Preventing Skin Cancer

> **NCT00025012** · NA · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)**

## Conditions studied

- Melanoma (Skin)
- Non-melanomatous Skin Cancer

## Interventions

- **DRUG:** isotretinoin

## Key facts

- **NCT ID:** NCT00025012
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-06
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025012, "Isotretinoin in Preventing Skin Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00025012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*